Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute November 29, 2024
Poseida Therapeutics, cell therapy maker, triples on Nasdaq after being acquired by Roche November 27, 2024
InvestorPlace Markets analyst highlights three small caps poised for a comeback in 2025 November 26, 2024
‘The higher the crime rate, the higher the demand for our services’: An interview with Ituran’s CEO November 26, 2024
